mRNA Licensing Deals Soar 800% Amid GSK Lawsuit Surge
mRNA-based innovator pharmaceuticals have experienced a massive increase in licensing agreement deal values following success with the technology in Covid-19 vaccines, which helped to curtail the pandemic. Data and analytics…